tbuckley/cabot-search huggingface dataset:
Potential Benefit of Low-Dose Candesartan in Trastuzumab-Induced Cardiotoxic Effects—Reply
Authors: Jan H. M. Schellens
Journal: JAMA Oncology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
TCT-302 Long-term Event Free Survival Rates for Successful Chronic Total Occlusions (CTOs) and Matched non-CTO Percutaneous Interventions are Substantially Better than In Persistent CTOs
Authors: Matjaž Bunc, Dinko Zavrl, Darko Zorman, Miha Mrak, Igor Kranjec
Journal: Journal of the American College of Cardiology (2016)
Mutant Wilms’ Tumor 1 (WT1) mRNA with Premature Termination Codons Is Sensitive to Nonsense-Mediated RNA Decay in Acute Myeloid Leukemia (AML)
Authors: Saman Abbas, Claudia Erpelinck, Chantal Goudswaard, B. Lowenberg, Peter Valk
Journal: Blood (2008)
PRECIOUS: A randomized, open-label phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients who were previously treated with pertuzumab, trastuzumab, and chemotherapy.
Authors: Yutaka Yamamoto, Hiroji Iwata, Takayuki Ueno, Masahiro Kashiwaba, Naruto Taira, Masato Takahashi, Hiroshi Tada, Koichiro Tsugawa, Tatsuya Toyama, Naoki Niikura, Fumikata Hara, Tomomi Fujisawa, Tetsuhiro Yoshinami, Shigehira Saji, Toshimi Takano, Norikazu Masuda, Satoshi Morita, Masakazu Toi, Shinji Ohno
Journal: Journal of Clinical Oncology (2016)

TPS636 Background: Combination of pertuzumab (Pmab) with trastuzumab (Tmab) has dramatically improved patients’ outcomes compared to Tmab as 1st line therapy in HER2-positive (+ve) locally advanced (LA)/metastatic breast cancer (MBC). However, it is unclear whether reexposure to this dual HER2-blockade is more effective than conventional treatment in HER2+ve LA/MBC patients previously receiving Pmab, Tmab, and chemotherapy (CT). Methods: Trial design: PRECIOUS (NCT02514681) is a multicenter randomized open-label phase III study enrolling HER2+ve LA/MBC patients pretreated with Pmab, Tmab, and CT. Patients are randomized 1:1 to receive CT of physician’s choice (docetaxel, paclitaxel, nab-paclitaxel, vinorelbine, or eribulin) plus Tmab with or without Pmab. Eligibility criteria: Patients received Pmab, Tmab, and CT for HER2+ve LA/MBC as 1st and/or 2nd line anti-HER2-containing CT. The latest regimen before enrollment does not include Pmab. The number of previous CT regimens for LA/MBC does not exceed three. Aims: The primary endpoint is investigator-assessed progression-free survival (PFS). Secondary endpoints include independent reviewer-assessed PFS, PFS in patients treated with T-DM1 as the latest regimen, response rate, duration of response, overall survival, safety, and patient-reported outcome. Translational researches using blood samples are also planned to find prognostic and predictive markers for patients receiving anti-HER2 treatment. Statistics: PFS between control arm (Tmab and CT) and experimental arm (Pmab, Tmab, and CT) will be compared using a log-rank test. Three-hundred and seventy patients will be enrolled that allow the observation of 325 events for 80% power to detect a hazard ratio of 0.739 at one-side 5% level of significance. Accrual status: Recruitment began in August 2015 and is expected to be completed in July 2018 in Japan. Clinical trial information: NCT02514681.
TCT-706 Histological Findings and Predictors for Cerebral Debris from Transcatheter Aortic Valve Replacement – the ALSTER experience
Authors: Tobias Schmidt, Ozan Akdag, Peter Wohlmuth, Thomas Thielsen, Dimitry Schewel, Hannes Alessandrini, Felix Kreidel, Ralf Bader, Maria Romero, Elena Ladich, Renu Virmani, Ulrich Schaefer, Karl-Heinz Kuck, Christian Frerker
Journal: Journal of the American College of Cardiology (2016)
TCT-365 Correlation between residual anticoagulation and radial artery occlusion after transradial catheterization: preliminary results from an Italian multicenter study
Authors: andrea pacchioni, Gabriele Pesarini, Carlo Penzo, riccardo turri, jayme ferro, alfredo fede, Salvatore Sacca, Tomoyuki Umemoto, Michele Bellamoli, Andrea Pavei, Antonio Mugnolo, Fabio Dell'Avvocata, Flavio Ribichini, bernhard reimers
Journal: Journal of the American College of Cardiology (2016)
LATENT VIRAL INFECTION OF CELLS IN TISSUE CULTURE
Authors: John P. Bader, Herbert R. Morgan
Journal: The Journal of Experimental Medicine (1961)

A study of the metabolic requirements for the growth of psittacosis virus in L cells has been extended to the water-soluble vitamins. In a system in which a balanced salt solution was used to deplete the cells of their vitamin constituents, only thiamine was essential for psittacosis virus production. Extended depletion of cells with media deficient in specific vitamins demonstrated that pantothenate, niacin (niacinamide), pyridoxine (pyridoxal), and choline, in addition to thiamine, were essential for maximal growth of psittacosis virus. No requirement for biotin, inositol, folic acid, or riboflavin was demonstrated, although the possibility of incomplete vitamin depletion of the cells has not been eliminated. In most cases in which a specific vitamin requirement was shown the decreased yield of virus was correlated with a delay in the cytopathic effects produced in the cell cultures by psittacosis virus.
TCT-130 Complete Myocardial Revascularisation is not Associated with a Better Prognosis in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction. Insight from the multicenter prospective ORBI registry.
Authors: Guillaume Leurent, Ronan Garlantezec, Vincent Auffret, Emmanuelle Filippi, Martine Gilard, Djamel Saouli, Jean-Philippe Hacot, Gilles Rouault, Regis Delaunay, Dominique Boulmier, Marc Bedossa, Hervé Le Breton
Journal: Journal of the American College of Cardiology (2016)
TCT-849 Radiation-Associated Lens Changes in the Cardiac Catheterization Laboratory: the IC-CATARACT (CATaracts Attributed to Radiation in the CaTh Lab) Initiative
Authors: Aris Karatasakis, Harilaos Brilakis, Barbara Anna Danek, Phuong-Khanh Nguyen-Trong, Judit Karacsonyi, Jose Roberto Martinez-Parachini, Aya Alame, Bavana Rangan, Michele Roesle, Charles Chambers, Kenneth Rosenfield, Roxana Mehran, Subhash Banerjee, Emmanouil Brilakis
Journal: Journal of the American College of Cardiology (2016)
Atacicept (TACI-Ig) Inhibits Growth of TACIhigh Primary Myeloma Cells in SCID-Hu Mice.
Authors: Shmuel Yaccoby, Stacey R. Dillon, Wen Ling, Paul Perkins, John R. Tisdale, Angela Pennisi, Rinku Saha, Xin Li, Bart Barlogie, Guido Tricot, Fenghuang Zhan, John Shaughnessy
Journal: Blood (2006)
TCT-787 The Evolution of Therapy For Infrainguinal Arterial Occlusive Disease: Improvement in Quality of Life With Endovascular Interventions via Transpedal Access
Authors: Apurva Patel, Roosha Parikh, Jeffrey Ma, Samuel Kolman, Justin Ratcliffe, Joseph Puma, Tak Kwan
Journal: Journal of the American College of Cardiology (2016)
Phase I trial combining SCH 66336 to temozolomide (TMZ) for patients with grade 3 or 4 malignant gliomas (MG)
Authors: A. Desjardins, D. A. Reardon, S. Gururangan, K. Peters, S. Threatt, A. Friedman, H. Friedman, J. Vredenburgh
Journal: Journal of Clinical Oncology (2009)

e13004 Background: Ras plays a crucial role in the control of cellular proliferation and differentiation. Farnesylation is an essential step in the post-translational processing of Ras. SCH 66336 inhibits farnesyl transferase, the crucial enzyme in this process. We report a phase I trial of TMZ and SCH 66336. Methods: Eligibility included: adult patients with stable or recurrent MG (GBM, anaplastic astrocytoma [AA], anaplastic oligodendroglioma [AO]) previously treated with radiation therapy (RT) and with or without chemotherapy; interval of at least two weeks between prior RT, or four weeks between prior chemotherapy; Karnofsky ≥ 60%; and adequate hematologic, renal and liver function. Patients were divided in two strata: those receiving enzyme-inducing antiepileptic drugs (EIAED) and those not receiving EIAED. Each patient was treated with TMZ for five days every 28 days, first cycle dosed at 150 mg/m 2 and subsequent cycles at 200 mg/m 2 . SCH 66336 was dosed orally daily and was dose escalated. Responses were assessed after two cycles (8 weeks). The primary endpoints of this study were to determine the maximum tolerated dose (MTD) of SCH 66336 when administered with TMZ, and the toxicity of this combination. Results: Thirty-six patients were enrolled (25 GBM, 6 AA, 3 AO). Fifteen patients have been accrued to the EIAED stratum at SCH 66336 doses of 125, 175, and 250 mg orally BID. Twenty-one patients have been accrued to the non-EIAED stratum at SCH 66336 doses of 75, 100, 150, and 200 mg orally BID. Dose-limiting toxicities were: deep venous thrombosis (1 grade 3); nausea and vomiting (1 grade 3); diarrhea (1 grade 3); elevated ALT (1 grade 3); elevated creatinine (1 grade 3); and fatigue (1 grade 3). Radiographic evaluation reported: 2 partial responses, 14 stable disease for at least 4 cycles, and 11 disease progression after either the first or second cycle. Sixteen patients have completed at least six cycles. One patient is still on treatment, completing cycle 12. The MTD of this combination for the EIAED stratum is 175 mg BID and the non-EIAED stratum is 150 mg BID. Conclusions: SCH 66336 in combination with TMZ is well-tolerated and shows promising response when administered to patient when stable on TMZ alone or after RT and TMZ. No significant financial relationships to disclose.
From TCR Gene Transfer to TCR Gene Editing of Central Memory T Lymphocytes for Immunotherapy of Leukemia.
Authors: Elena Provasi, Pietro Genovese, Zulma Magnani, Oscar Muniz Pello, Jurgen Kuball, Angelo Lombardo, Attilio Bondanza, Philip D. Gregory, Claudio Bordignon, Michael C. Holmes, Philip D. Greenberg, Luigi Naldini, Chiara Bonini
Journal: Blood (2009)
NARROW BAND IMAGING VERSUS LUZ BLANCA EN LA CARACTERIZACIÓN DE NEOPLASIA RESIDUAL TRAS RESECCIÓN ENDOSCÓPICA MUCOSA, ESTUDIO CONTROLADO Y ALEATORIZADO
Authors: F Riu Pons, M Andreu, J Gimeno, MA Álvarez, A Seoane, JM Dedeu, L Barranco, X Bessa
Journal: Endoscopy (2016)

La Resección Endoscópica Mucosa (REM) de pólipos colorrectales sésiles se asocia a una recurrencia de alrededor del 25%. No existe evidencia si NBI respecto Luz blanca (LB) pueda mejorar la detección de tejido residual en el seguimiento de estas lesiones.
TCT-307 Factors involved in the decision making process and prognosis implications of the different kind of treatment given to patients with chronic coronary occlusion
Authors: None victoria martin yuste, None ignacio ferreira, None eduardo flores, None marco hernandez, Kohki Ishida, None gustavo jimenez, Xavier Freixa, None salvatore brugaletta, Manel Sabate
Journal: Journal of the American College of Cardiology (2016)
INDICADORES DE CALIDAD EN LA ESOFAGO-GASTRO-DUODENOSCOPIA: ESTUDIO COMPARATIVO DE LOS RESULTADOS TRAS UN PROGRAMA DE MEJORA EN UN HOSPITAL TERCIARIO
Authors: PG Delgado-Guillena, C Sánchez-Montes, H Córdova, VJ Morales-Alvarado, À Ginés, O Sendino, A Cárdenas, IK Araujo, J Llach, G Fernández-Esparrach
Journal: Endoscopy (2016)

Introducción: El registro y la medición de los indicadores de calidad suponen una oportunidad de mejora del endoscopista y de las unidades de endoscopia. Sin embargo, no existen experiencias previas en nuestro medio sobre su cumplimiento ni cuánto pueden mejorar tras la realización de un programa de formación.
TCT-672 Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and Evolut R platforms in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM
Authors: Paul Sorajja, Susheel Kodali, Michael J. Reardon, Wilson Y. Szeto, Stanley Chetcuti, James B. Hermiller, David H. Adams, Jeffrey J. Popma, Jessica Dries-Devlin
Journal: Journal of the American College of Cardiology (2016)
Review: Found in Translation: International Initiatives Pursuing Interleukin‐1 Blockade for Treatment of Acute Kawasaki Disease
Authors: Jane C. Burns, Isabelle Koné‐Paut, Taco Kuijpers, Chisato Shimizu, Adriana Tremoulet, Moshe Arditi
Journal: Arthritis & Rheumatology (2016)

The decision to move forward with three clinical trials of IL-1 blockade for treatment of acute Kawasaki disease is a case study in translational science. These trials were born on the one hand from transcriptome studies of host response during the acute disease coupled with animal model investigations of key immune signaling pathways and, on the other hand, out of clinical desperation to intervene in patients with severe inflammation in the setting of acute Kawasaki disease. The convergence of laboratory science and clinical observations led to the clinical trials described here and serves as a model for how such observations can be translated into new therapies. This article is protected by copyright. All rights reserved.
Mice Deficient in the Fifth Complement Cascade Protein (C5) Do Not Display Circadian Changes in the Number of Circulating Hematopoietic Stem/Progenitor Cells (HSPCs) in Peripheral Blood (PB)—evidence for the Pivotal Role of the Distal Part of the Complement Cascade in Inducing the Circadian Release of HSPCs into PB
Authors: Sylwia Borkowska, Malwina Suszynska, Janina Ratajczak, Mariusz Z Ratajczak
Journal: Blood (2014)
TCT-214 GLP-1 cardioprotection against ischemic dysfunction in humans is not mediated by a mitochondrial K-ATP dependent pathway in left ventricular conductance catheter studies
Authors: Joel Giblett, Richard Axell, Paul White, Sophie Clarke, Philip Read, Liam McCormick, Adam Brown, Michael O'Sullivan, Nick West, David Dutka, Stephen Hoole
Journal: Journal of the American College of Cardiology (2016)
Gene-corrected human Munc13-4–deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice
Authors: Tayebeh Soheili, Julie Rivière, Ida Ricciardelli, Amandine Durand, Els Verhoeyen, Anne-Céline Derrien, Chantal Lagresle-Peyrou, Geneviève de Saint Basile, François-Loïc Cosset, Persis Amrolia, Isabelle André-Schmutz, Marina Cavazzana
Journal: Blood (2016)
TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
Authors: Gennaro Giustino, Roxana Mehran, Ajay Kirtane, Bjorn Redfors, Philippe Généreux, George Dangas, Sorin Brener, Jayne Prats, Makis Deliargyris, Gregg Stone
Journal: Journal of the American College of Cardiology (2016)
Prognostic significance of patient-physician disagreement about performance status in patients with advanced cancer
Authors: I. D. Schnadig, E. K. Fromme, C. L. Loprinzi, J. A. Sloan, M. Mori, H. Li, T. M. Beer, N. Perrin
Journal: Journal of Clinical Oncology (2007)

9021 Background: Physician-reported performance status (PS) is an important prognostic factor in advanced malignancies and is a commonly used stratification variable in cancer clinical trials. However, the extent, predictors, and prognostic importance of disagreement in PS assessment between physicians and patients have not been examined. Methods: Using NCCTG clinical trials from 1987–1990 (J Clin Oncol 19(15):3539–3546, 2001), we analyzed the difference and agreement of PS (ECOG and Karnofsky [KPS]) and nutritional status assessments reported by physicians and patients individually. The degree of disagreement was analyzed using paired t-test. Overall mortality was estimated by Kaplan-Meier method. The effect of disagreement on overall survival was analyzed by Cox regression. Independent predictors of disagreement were identified by logistic regression. Results: 1,636 patients with advanced lung and colorectal cancer had a median survival of 9.8 months (95% CI, 9.4 to 10.4). Percent agreement between patients and physicians about KPS, ECOG PS, and appetite/nutritional status was 32.9%, 43.4% and 42.0% respectively. Physicians were more likely to rate patients better than individual patients were to rate themselves: ECOG (Mean 0.91 vs 1.30, p&lt;.0001), KPS (Mean 83.3 vs. 81.7, p&lt;0.0001), appetite/nutritional status (Mean 1.6 vs. 2.1, p&lt;0.0001). Inability to work, depression and less than a high school education were independently associated with disagreement. An increased risk of death was observed for patient and physician disagreement on KPS (HR=1.15, 95% CI, 1.03 to 1.27 p=0.01) and appetite/nutritional status (HR=1.39, 95% CI, 1.26 to 1.54 p&lt;0.0001). Conclusions: Patients and physicians frequently disagree about patient PS, with physicians tending to rate patients higher than patients do themselves. Baseline patient demographic factors that independently predict disagreement have been identified. Disagreement confers an increased risk of death in the setting of advanced malignancies. These findings illustrate limitations of physician-only assessed PS. No significant financial relationships to disclose.
TCT-419 Usefulness of a scoring system for predicting adverse cardiovascular events in patients undergoing everolimus-eluting bioresorbable scaffolds implantation: the PSP score
Authors: Luis Ortega-Paz, Davide Capodanno, Tommaso Gori, Holger Nef, Azeem Latib, Giuseppe Caramanno, Carlo Di Mario, Christoph Naber, Maciej Lesiak, Piera Capranzano, Jens Wiebe, Julinda Mehilli, Aleksander Araszkiewicz, Stelios Pyxaras, Alessio Mattesini, Salvatore Geraci, Toru Naganuma, Antonio Colombo, Thomas Münzel, Manel Sabate, Corrado Tamburino, Salvatore Brugaletta
Journal: Journal of the American College of Cardiology (2016)
TCT-547 Radial artery changes after transradial PCI – A serial optical coherence tomography volumetric study
Authors: Jan Kanovsky, Tereza Novakova, Roman Miklik, Otakar Bocek, Martin Poloczek, Lenka Privarova, Petr Jerabek, Tomas Ondrus, Jiri Jarkovsky, Milan Blaha, Petr Kala
Journal: Journal of the American College of Cardiology (2016)
Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM): RKIP Overexpression and RKIP Phosphorylation Is Common in MM Tumor Cells
Authors: Stavroula Baritaki, Sara Huerta-Yepez, Ma de Lourdes Cabera-Muñoz, Clara Rivera-Pazos, Kam Yeung, Manuel L Penichet, Haiming Chen, James R. Berenson, Benjamin Bonavida
Journal: Blood (2008)
Test medical students while preclinical
Authors: A G Elder
Journal: BMJ (1994)

EDITOR,--A M L Lever may be right in declaring that routine testing for hepatitis B e antigen before students enter medical school sets a dangerous precedent but is wrong to imply that infected students present no risk to patients.1 Medical students are likely to help in theatre during their clinical years and during the preregistration year as house surgeons. Unless universities alter the curriculums to abolish such clinical experience or the …
Fludarabine Plus Cyclophosphamide and Rituximab (RFC) in Waldenström’s Macroglobulinemia (WM): Results in 21 Patients (pts).
Authors: Jacques Vargaftig, Brigitte Pegourié-Bandelier, Béatrice Mahé, Steven Le Gouill, Elisabeth Brottier-Mancini, Richard Delarue, Agnès Buzyn, Martine Raphael, Sylvain Choquet, Véronique Leblond
Journal: Blood (2006)
TCT-484 Difference in Restenosis Pattern and Related Clinical Presentation between Early, Late, and Very Late Restenosis after Sirolimus-Eluting Stent Implantation
Authors: Shunsuke Kubo, Akimune Kuwayama, Takenobu Shimada, katsuya miura, Masanobu Ohya, Hidewo Amano, Yusuke Hyodo, Suguru Otsuru, Seiji Habara, Takeshi Tada, Hiroyuki Tanaka, Yasushi Fuku, Tsuyoshi Goto, Kazushige Kadota
Journal: Journal of the American College of Cardiology (2016)
TCT-843 Preclinical Evaluation of the SELUTION™ Sirolimus Drug Coated Balloon in a Porcine Coronary Overstretch Model
Authors: Robert J. Elicker, John E. Shulze, Michael T. Ahlering, Scott H. Barnhill, Ronald K. Yamamoto, Jurjen Zoethout
Journal: Journal of the American College of Cardiology (2016)
TCT-18 Validation of Wound, Ischemia, foot Ischemia (WIFI) classification system in Japanese patients after endovascular treatment for critical limb ischemia (CLI).
Authors: Takahiro Tokuda, Keisuke Hirano, Yoshiaki Ito, Masahiro Yamawaki, Motoharu Araki, Norihiro Kobayashi, Hideyuki Takimura, Shinsuke Mori, Yasunari Sakamoto, Masakazu Tsutsumi, Takuro Takama, Kenji Makino
Journal: Journal of the American College of Cardiology (2016)
EXPERIENCIA DEL USO DE LA ENTEROSCOPIA EN EL HOSPITAL UNIVERSITARIO VIRGEN MACARENA
Authors: MF Guerra Veloz, M Belvis, B Gómez Rodríguez, P Hergueta Delgado, A Caunedo Alvarez
Journal: Endoscopy (2016)

La enteroscopia de balón complementa a la cápsula endoscópica en el diagnóstico de las lesiones del intestino delgado. La enteroscopia asistida por mono y doble balón tiene una eficacia similar.
Simple and Specific Grafting of Antibacterial Peptides on Silicone Catheters
Authors: Coline Pinese, Said Jebors, Cécile Echalier, Patricia Licznar‐Fajardo, Xavier Garric, Vincent Humblot, Christophe Calers, Jean Martinez, Ahmad Mehdi, Gilles Subra
Journal: Advanced Healthcare Materials (2016)

To fight against nosocomial infection initiated by colonization of medical devices, a strategy enabling the direct and fast functionalization of silicone surfaces is proposed. This strategy proceeds in a site‐specific way using original hybrid silylated antibacterial peptides. This safe and up‐scalable method guarantees a covalent and robust immobilization with the correct orientation of the bioactive moiety. Importantly it also avoids multi‐step chemical modifications of the surface or multi‐layer polymer coatings. As proof of concept, antibacterial silicone catheter has been prepared whose immediate and long term efficiency is superior by comparison to similar silver‐embedded materials.
Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia
Authors: P N Ojamies, M Kontro, H Edgren, P Ellonen, S Lagström, H Almusa, T Miettinen, S Eldfors, D Tamborero, K Wennerberg, C Heckman, K Porkka, M Wolf, O Kallioniemi
Journal: Leukemia (2016)
P0291 : The oncostatic action of sorafenib on liver cancer cells is changed to an oncolytic effect following pre-treatment with chloroquine: Demonstration of synergy between chloroquine and sorafenib as a potential novel approach to treatment of HCC
Authors: F. De Chiara, R.C. Montella, F. Andreola, R. Jalan
Journal: Journal of Hepatology (2015)
TCT-446 Fluoropassivation of Coronary Stents as a Potential Mechanism of Improved Thromboresistance
Authors: Sho Torii, Frank Kolodgie, Eduardo Acampado, Kazuyuki Yahagi, Hiroyoshi Mori, Maria Romero, Laura Perkins, Syed Hossainy, Stephen Pacetti, Aloke Finn, Renu Virmani, Qi Cheng
Journal: Journal of the American College of Cardiology (2016)